These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 35860803)

  • 1. CLK2 Expression Is Associated with the Progression of Colorectal Cancer and Is a Prognostic Biomarker.
    Lin J; Lin G; Chen B; Yuan J; Zhuang Y
    Biomed Res Int; 2022; 2022():7250127. PubMed ID: 35860803
    [TBL] [Abstract][Full Text] [Related]  

  • 2. INHBB Is a Novel Prognostic Biomarker Associated with Cancer-Promoting Pathways in Colorectal Cancer.
    Yuan J; Xie A; Cao Q; Li X; Chen J
    Biomed Res Int; 2020; 2020():6909672. PubMed ID: 33083477
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CDC Like Kinase 2 plays an oncogenic role in colorectal cancer via modulating the Wnt/β-catenin signaling.
    Zhou HB; Yang L; Liu SF; Xu XH; Chen Z; Li YX; Yuan JH; Wei YC
    Neoplasma; 2022 May; 69(3):657-669. PubMed ID: 35293765
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CX3CR1 Acts as a Protective Biomarker in the Tumor Microenvironment of Colorectal Cancer.
    Yue Y; Zhang Q; Sun Z
    Front Immunol; 2021; 12():758040. PubMed ID: 35140706
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tumor microenvironment-related gene selenium-binding protein 1 (SELENBP1) is associated with immunotherapy efficacy and survival in colorectal cancer.
    Zhu C; Wang S; Du Y; Dai Y; Huai Q; Li X; Du Y; Dai H; Yuan W; Yin S; Wang H
    BMC Gastroenterol; 2022 Oct; 22(1):437. PubMed ID: 36253721
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Grid2 interacting protein is a potential biomarker related to immune infiltration in colorectal cancer.
    Zhao J; Quan J; Chen W; Xie X
    Eur J Med Res; 2023 Nov; 28(1):511. PubMed ID: 37964339
    [TBL] [Abstract][Full Text] [Related]  

  • 7. NDUFA4L2 is a novel biomarker for colorectal cancer through bioinformatics analysis.
    Lin Y; Xie H; Zhao W; Li Y; Zhang Z
    Medicine (Baltimore); 2023 Nov; 102(44):e35893. PubMed ID: 37933010
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of prognostic immune-related gene signature associated with tumor microenvironment of colorectal cancer.
    Wang Y; Li W; Jin X; Jiang X; Guo S; Xu F; Su X; Wang G; Zhao Z; Gu X
    BMC Cancer; 2021 Aug; 21(1):905. PubMed ID: 34364366
    [TBL] [Abstract][Full Text] [Related]  

  • 9. LncRNA SNHG6 promotes proliferation, invasion and migration in colorectal cancer cells by activating TGF-β/Smad signaling pathway via targeting UPF1 and inducing EMT via regulation of ZEB1.
    Wang X; Lai Q; He J; Li Q; Ding J; Lan Z; Gu C; Yan Q; Fang Y; Zhao X; Liu S
    Int J Med Sci; 2019; 16(1):51-59. PubMed ID: 30662328
    [No Abstract]   [Full Text] [Related]  

  • 10. Development of an Immune Infiltration-Related Eight-Gene Prognostic Signature in Colorectal Cancer Microenvironment.
    Wu B; Tao L; Yang D; Li W; Xu H; He Q
    Biomed Res Int; 2020; 2020():2719739. PubMed ID: 32908876
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increased expression of NOP14 is associated with improved prognosis due to immune regulation in colorectal cancer.
    Lu C; Liao W; Huang Y; Huang Y; Luo Y
    BMC Gastroenterol; 2022 Apr; 22(1):207. PubMed ID: 35473611
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of biomarkers associated with diagnosis and prognosis of colorectal cancer patients based on integrated bioinformatics analysis.
    Chen L; Lu D; Sun K; Xu Y; Hu P; Li X; Xu F
    Gene; 2019 Apr; 692():119-125. PubMed ID: 30654001
    [TBL] [Abstract][Full Text] [Related]  

  • 13. PRKRIP1, A Splicing Complex Factor, Is a Marker of Poor Prognosis in Colorectal Cancer.
    Ozato Y; Masuda T; Kobayashi Y; Takao S; Hisamatu Y; Toshima T; Yonemura Y; Uemura M; Eguchi H; Doki Y; Mori M; Mimori K
    Anticancer Res; 2022 Oct; 42(10):4701-4706. PubMed ID: 36192001
    [TBL] [Abstract][Full Text] [Related]  

  • 14. TNNT2 as a potential biomarker for the progression and prognosis of colorectal cancer.
    Jing L; Feng L; Zhou Z; Shi S; Deng R; Wang Z; Zhang Y; Ren Z; Liu Y
    Oncol Rep; 2020 Aug; 44(2):628-636. PubMed ID: 32627044
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of Genes Related to 5-Fluorouracil Based Chemotherapy for Colorectal Cancer.
    Huang X; Ke K; Jin W; Zhu Q; Zhu Q; Mei R; Zhang R; Yu S; Shou L; Sun X; Feng J; Duan T; Mou Y; Xie T; Wu Q; Sui X
    Front Immunol; 2022; 13():887048. PubMed ID: 35784334
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical Prognostic Significance of HOXC9 Expression in Patients with Colorectal Cancer.
    Hu M; Ou-Yang W; Jing D; Chen R
    Clin Lab; 2019 Aug; 65(8):. PubMed ID: 31414766
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oncogenic splicing abnormalities induced by DEAD-Box Helicase 56 amplification in colorectal cancer.
    Kouyama Y; Masuda T; Fujii A; Ogawa Y; Sato K; Tobo T; Wakiyama H; Yoshikawa Y; Noda M; Tsuruda Y; Kuroda Y; Eguchi H; Ishida F; Kudo SE; Mimori K
    Cancer Sci; 2019 Oct; 110(10):3132-3144. PubMed ID: 31390121
    [TBL] [Abstract][Full Text] [Related]  

  • 18. NAT1 is a critical prognostic biomarker and inhibits proliferation of colorectal cancer through modulation of PI3K/Akt/mTOR.
    Cai J; Sun H; Chen L; Xie M; Zhuang J; Gao L; Wei XX
    Future Oncol; 2021 Jul; 17(19):2489-2498. PubMed ID: 33906370
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Integrated Analysis of Expression and Prognostic Values of Acyl-CoA Dehydrogenase short-chain in Colorectal Cancer.
    Wu Q; Yan T; Chen Y; Chang J; Jiang Y; Zhu D; Wei Y
    Int J Med Sci; 2021; 18(16):3631-3643. PubMed ID: 34790035
    [No Abstract]   [Full Text] [Related]  

  • 20. A Prognostic Model Based on Six Metabolism-Related Genes in Colorectal Cancer.
    Sun YL; Zhang Y; Guo YC; Yang ZH; Xu YC
    Biomed Res Int; 2020; 2020():5974350. PubMed ID: 32953885
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.